BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Oncolytics Biotech, Adlai Nortye Forge $86.6M Reolysin Deal

  Under the terms of The Agreement, Adlai will have exclusive development and commercialization rights to REOLYSIN in China, Hong Kong, Macau, Singapore, South Korea and Taiwan.

  November 16, 2017

   · 

  8 min read
• Pharm Country

  Teleflex Incorporated Announces Pricing of $500M Senior Notes Offering

  The sale of the Notes is expected to close on November 20, 2017, subject to customary closing conditions.

  November 16, 2017

   · 

  3 min read
• Business

  David C. Pacitti Joins Apollo Endosurgery Board of Directors

  He will commence service on December 8, 2017.

  November 16, 2017

   · 

  2 min read
• Business

  Lifeloc Reports Third Quarter 2017 Results

  The Company posted quarterly net revenue of $2.00 million for a quarterly net income of $190, or $0.00 per diluted share.

  November 16, 2017

   · 

  7 min read
• Evonik Industries : Opens Third Dimension to Classrooms Worldwide

  Evonik Industries presents a new generation of the cyber classroom at international science conference in Tokyo

  November 16, 2017

   · 

  3 min read
• Array BioPharma Announces Private Exchange of $107M of its 3.00% Convertible Senior Notes Due 2020 for its 2.625% Convertible Senior Notes Due 2024 and Shares of its Common Stock

  The Company anticipates that the settlement of the transactions under the exchange agreements will occur on or about December 1, 2017, subject to satisfaction of customary closing conditions.

  November 16, 2017

   · 

  6 min read
• Business

  SCYNEXIS Appoints Scott Sukenick as General Counsel

  Mr. Sukenick will be responsible for leading the Company’s corporate strategic and tactical legal initiatives, including intellectual property and compliance.

  November 16, 2017

   · 

  3 min read
• Ampio Pharma Announces Continued Listing Plan Accepted by NYSE American

  Ampio Pharmac today announced the receipt of notification that the Company’s plan to regain compliance with the NYSE American’s continued listing standards has been accepted by the NYSE American.

  November 16, 2017

   · 

  3 min read
• 

  Business

  All Systems Go: Johnson & Johnson Reaches Out for Second Ionis GI Drug

  Ionis Pharma and Janssen have strengthened their alliance with a second deal for gastrointestinal drugs.

  November 16, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  Founded by Genzyme Alumni, Cambridge’s X4 Pharma Scores $27M

  The company plans to use the cash to advance its two lead drug programs into the clinic.

  November 16, 2017

   · 

  2 min read

   · 

  Mark Terry